Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2020 | Kite Konnect and upcoming milestones in 2020

Bethany Dudek • 30 Jan 2020
CAR-T Meeting 2020
Lymphoma Mantle Cell Lymphoma Non-Hodgkin Lymphoma CAR-T

Bethany Dudek, Kite Pharma, a Gilead Company, Amsterdam, The Netherlands, discusses Kite Konnect, an IT platform used by doctors to request treatment but also by the Kite organization to trace the CAR T-cell products. Additionally, this platform is also important for the supply chain organization. Ms Dudek highlights the new manufacturing facility in The Netherlands and reveals they are looking forward to new indications for axicabtagene ciloleucel in Europe.

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals